AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMRICOR MEDICAL SYSTEMS-CDI

1.440

+0.0553.97%

Volume:338.93K

Turnover:483.15K

Market Cap:516.30M

PE:-8.22

High:1.475

Open:1.400

Low:1.380

Close:1.385

52wk High:2.250

52wk Low:1.275

Shares:358.54M

Float Shares:275.05M

Volume Ratio:1.49

T/O Rate:0.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.175

EPS(LYR):-0.117

ROE:-143.12%

ROA:-26.53%

PB:12.42

PE(LYR):-12.27

Loading ...

Overview Company News Filings

Concept

Tech Companies+0.13%

Pharmaceutical Companies+0.54%

Capital Flow

Inflow:

Outflow:

News

Imricor Medical Systems Says FDA Completes Review of PMA Module Three

MT Newswires Live

Imricor Medical Systems - FDA Completes Review of Imricor's Third Pma Module

THOMSON REUTERS

Imricor Medical Systems - no Deficiencies Identified for Vision-Mr Ablation Catheter 2.0

THOMSON REUTERS

Imricor Medical Systems - Preparing Response to FDA for Module 3 Closure

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigerhkgo.com/stock/IMR.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IMR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":1.44,"timestamp":1791770943264,"preClose":1.385,"halted":0,"volume":338926,"delay":0,"changeRate":0.039711191335740026,"nameEN":"IMRICOR MEDICAL SYSTEMS-CDI","floatShares":275046474,"shares":358542497,"eps":-0.17524087465934204,"marketStatus":"Trading","change":0.055,"latestTime":"10-12 13:09:09 AEDT","open":1.4,"high":1.475,"low":1.38,"amount":483153,"amplitude":0.068592,"askPrice":1.44,"askSize":1156,"bidPrice":1.435,"bidSize":1718,"shortable":3,"etf":0,"ttmEps":-0.17524087465934204,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791781200000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":1.385,"openAndCloseTimeList":[[1791759600000,1791781200000]],"volumeRatio":1.486601,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMR.AU","preClose":1.385,"auctionPrice":1.4,"auctionVolume":14704,"auctionTime":1791759542487,"referenceTime":1791541803093,"auction":1,"marketStatus":"盘前竞价","timestamp":1791759542487}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":275046474,"roa":"-26.53%","roe":"-143.12%","lyrEps":-0.117312,"volumeRatio":1.486601,"shares":358542497,"dividePrice":0,"high":1.475,"amplitude":0.068592,"preClose":1.385,"low":1.38,"week52Low":1.275,"pbRate":"12.42","psRate":"3005.59","week52High":2.25,"institutionHeld":0,"latestPrice":1.44,"committee":0.195546,"eps":-0.17524087465934204,"divideRate":0,"volume":338926,"delay":0,"ttmEps":-0.17524087465934204,"open":1.4,"prevYearClose":1.53,"prevWeekClose":1.385,"prevMonthClose":1.585,"prevQuarterClose":1.585,"fiveDayClose":1.55,"twentyDayClose":1.85,"sixtyDayClose":1.66,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-10","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786320000000,"name":null,"time":"","dateTimestamp":1786284000000,"actualEps":null},{"date":"2026-02-24","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771887600000,"name":null,"time":"","dateTimestamp":1771851600000,"actualEps":null},{"date":"2025-08-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756166400000,"name":null,"time":"","dateTimestamp":1756130400000,"actualEps":null},{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673046364","title":"Imricor Medical Systems Says FDA Completes Review of PMA Module Three","url":"https://stock-news.laohu8.com/highlight/detail?id=2673046364","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673046364?lang=en_us&edition=fundamental","pubTime":"2026-10-08 07:41","pubTimestamp":1791416498,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said the US Food and Drug Administration has completed its review of module three of the company's premarket approval  submission, which covers non-clinical bench testing for its Vision-MR ablation catheter 2.0, RF-5000 system and irrigation tubing set, according to a Thursday Australian bourse filing.No deficiencies were identified in the catheter or tubing set, while one deficiency was found in the RF-5000 system's third-party software operating system, which the company has already upgraded to a long-term supported version, per the filing.The company is preparing its response to the FDA, with module three expected to close upon acceptance and module four targeted for submission in November, thereby completing all PMA submissions, the filing added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK7007","LABU","BK7508","BK4588","BK4129","BK7503","PMA","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673430360","title":"Imricor Medical Systems - FDA Completes Review of Imricor's Third Pma Module","url":"https://stock-news.laohu8.com/highlight/detail?id=2673430360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673430360?lang=en_us&edition=fundamental","pubTime":"2026-10-08 06:18","pubTimestamp":1791411483,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45T23P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7503","BK7007","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673043039","title":"Imricor Medical Systems - no Deficiencies Identified for Vision-Mr Ablation Catheter 2.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2673043039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673043039?lang=en_us&edition=fundamental","pubTime":"2026-10-08 06:18","pubTimestamp":1791411483,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45T23P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7007","IMR.AU","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673031043","title":"Imricor Medical Systems - Preparing Response to FDA for Module 3 Closure","url":"https://stock-news.laohu8.com/highlight/detail?id=2673031043","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673031043?lang=en_us&edition=fundamental","pubTime":"2026-10-08 06:18","pubTimestamp":1791411483,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45T23P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMR.AU","BK7508","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IMR.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Tech Companies","id":"package_au_concept_kjg","bkCode":"BK7503","changeRate":0.001331},{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.005399}]}}